{"data":{"allContentfulMenuItem":{"edges":[{"node":{"slug":"our-science","position":"3","title":"Our Science","description":{"content":[{"content":[{"value":"Our Science"}]}]},"spaceId":"2jhpzpp9rwmu","default_template":[{"slug":"clinical-trials","title":"Clinical Trials ","position":null,"parentMenu":{"slug":"our-science"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"clinical-resources","position":"2","title":"Therapeutic Areas","description":{"content":[{"content":[{"value":"Diurnal is dedicated to developing new treatments to aid lifelong treatment for rare and chronic endocrine conditions\n\n"}]}]},"spaceId":"2jhpzpp9rwmu","default_template":[{"slug":"adrenal-insufficiency","title":"Adrenal Insufficiency","position":"2","parentMenu":{"slug":"clinical-resources"}},{"slug":"congenital-adrenal-hyperplasia","title":"Congenital Adrenal Hyperplasia","position":"1","parentMenu":{"slug":"clinical-resources"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"products","position":"1","title":"Products","description":{"content":[{"content":[{"value":"Founded in 2004, DIURNAL_SUPERSCRIPTTM_, a NEUROCRINE BIOSCIENCES_SUPERSCRIPTTM_ Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency."}]}]},"spaceId":"2jhpzpp9rwmu","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":[{"slug":"alkindi-r-hydrocortisone-granules-in-capsules-for-opening","title":"Alkindi® (Hydrocortisone Granules In Capsules For Opening)","position":"1","parentMenu":{"slug":"products"}},{"slug":"efmody-r-hydrocortisone-modified-release-hard-capsules","title":"Efmody® (hydrocortisone modified-release hard capsules)","position":"2","parentMenu":{"slug":"products"}}],"current_vacancies_template":null}},{"node":{"slug":"transparency","position":"4","title":"Transparency","description":{"content":[{"content":[{"value":"Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear\nrequirements for transparency.\n\n"}]},{"content":[{"value":"\n\n"}]}]},"spaceId":"2jhpzpp9rwmu","default_template":null,"cards_only_template":null,"tabs_for_files_template":[{"slug":"overview","title":"Overview","position":"1","parentMenu":{"slug":"transparency"}}],"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"careers","position":"5","title":"Careers","description":{"content":[{"content":[{"value":"Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities."}]}]},"spaceId":"2jhpzpp9rwmu","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":[{"slug":"why-join-us","title":"Why Join Us?","position":null,"parentMenu":{"slug":"careers"}}]}},{"node":{"slug":"awards","position":"6","title":"Awards","description":{"content":[{"content":[{"value":"A limited number of awards is available each year, and all applications will be judged objectively by an independent panel.\n\n"}]}]},"spaceId":"2jhpzpp9rwmu","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"transparency","position":"4","title":"Transparency","description":{"content":[{"content":[{"value":"Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear\nrequirements for transparency.\n\n"}]}]},"spaceId":"qzd1spzkopy8","default_template":null,"cards_only_template":null,"tabs_for_files_template":[{"slug":"overview","title":"Overview","position":"1","parentMenu":{"slug":"transparency"}}],"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"careers","position":"6","title":"Careers","description":{"content":[{"content":[{"value":"Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities.\n\n"}]}]},"spaceId":"qzd1spzkopy8","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":[{"slug":"why-join-us","title":"Why Join Us?","position":null,"parentMenu":{"slug":"careers"}}]}},{"node":{"slug":"information-for-patients","position":"3","title":"Information for patients","description":{"content":[{"content":[{"value":"This section is a resource providing information on Diurnal medicines available in the UK. It is not intended to replace the advice of a qualified doctor.\n\n"}]}]},"spaceId":"qzd1spzkopy8","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":[{"slug":"administration-instructions-for-neurocrine-patients","title":"Administration Instructions for Neurocrine Patients","position":"1","parentMenu":{"slug":"information-for-patients"}}],"current_vacancies_template":null}},{"node":{"slug":"our-science","position":"3","title":"Our Science","description":{"content":[{"content":[{"value":"Our Science"}]}]},"spaceId":"bm339k2zg0t6","default_template":[{"slug":"clinical-trials","title":"Clinical Trials ","position":null,"parentMenu":{"slug":"our-science"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"clinical-resources","position":"2","title":"Therapeutic Areas","description":{"content":[{"content":[{"value":"Diurnal is dedicated to developing new treatments to aid lifelong treatment for rare and chronic endocrine conditions"}]},{"content":[{"value":""}]}]},"spaceId":"bm339k2zg0t6","default_template":[{"slug":"adrenal-insufficiency","title":"Adrenal Insufficiency","position":"2","parentMenu":{"slug":"clinical-resources"}},{"slug":"congenital-adrenal-hyperplasia","title":"Congenital Adrenal Hyperplasia","position":"1","parentMenu":{"slug":"clinical-resources"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"products","position":"1","title":"Products","description":{"content":[{"content":[{"value":"Founded in 2004, DIURNAL_SUPERSCRIPTTM_, a NEUROCRINE BIOSCIENCES_SUPERSCRIPTTM_ Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency."}]}]},"spaceId":"bm339k2zg0t6","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":[{"slug":"alkindi-r-hydrocortisone-granules-in-capsules-for-opening","title":"Alkindi® (hydrocortisone granules in capsules for opening)","position":"1","parentMenu":{"slug":"products"}},{"slug":"efmody-r-hydrocortisone-modified-release-hard-capsules","title":"Efmody® (hydrocortisone modified-release hard capsules)","position":"2","parentMenu":{"slug":"products"}}],"current_vacancies_template":null}},{"node":{"slug":"transparency","position":"4","title":"Transparency","description":{"content":[{"content":[{"value":"Diurnal is committed to transparency in its interactions. Diurnal commits to following relevant pharmaceutical codes and has published details of its transfers of value.\n\n\n\n"}]}]},"spaceId":"bm339k2zg0t6","default_template":null,"cards_only_template":null,"tabs_for_files_template":[{"slug":"overview","title":"Overview","position":"1","parentMenu":{"slug":"transparency"}}],"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"careers","position":"5","title":"Careers","description":{"content":[{"content":[{"value":"Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities.\n\n"}]}]},"spaceId":"bm339k2zg0t6","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":[{"slug":"why-join-us","title":"Why Join Us?","position":null,"parentMenu":{"slug":"careers"}}]}},{"node":{"slug":"awards","position":"6","title":"Awards","description":{"content":[{"content":[{"value":"A limited number of awards is available each year, and all applications will be judged objectively by an independent panel.\n"}]}]},"spaceId":"bm339k2zg0t6","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"about-us","position":"1","title":"About us","description":{"content":[{"content":[{"value":"Founded in 2004, DIURNAL_SUPERSCRIPTTM_, a NEUROCRINE BIOSCIENCES_SUPERSCRIPTTM_ Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency."}]}]},"spaceId":"gbkvzr053a9z","default_template":[{"slug":"company-profile","title":"Company Profile","position":"1","parentMenu":{"slug":"about-us"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"transparency","position":"4","title":"Transparency","description":{"content":[{"content":[{"value":"Diurnal is committed to transparency in its interactions. Diurnal commits to following relevant pharmaceutical codes and has published details of its transfers of value."}]},{"content":[{"value":""}]},{"content":[{"value":""}]}]},"spaceId":"gbkvzr053a9z","default_template":null,"cards_only_template":null,"tabs_for_files_template":[{"slug":"overview","title":"Overview","position":"1","parentMenu":{"slug":"transparency"}}],"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"careers","position":"5","title":"Careers","description":{"content":[{"content":[{"value":"Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities.\n\n"}]}]},"spaceId":"gbkvzr053a9z","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":[{"slug":"why-join-us","title":"Why Join Us?","position":null,"parentMenu":{"slug":"careers"}}]}},{"node":{"slug":"information-for-patients","position":"3","title":"Information for patients","description":{"content":[{"content":[{"value":"This section is a resource providing information on Diurnal medicines available in the EU.  It is not intended to replace the advice of a qualified doctor.\n\n"}]}]},"spaceId":"gbkvzr053a9z","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":[{"slug":"information-on-efmody-for-patients","title":"Information on Efmody® (hydrocortisone modified-release hard capsules) for Patients","position":"2","parentMenu":{"slug":"information-for-patients"}},{"slug":"Information-on-alkindi-for-patients","title":"Information on Alkindi® (hydrocortisone granules in capsules for opening) for Patients","position":"1","parentMenu":{"slug":"information-for-patients"}}],"current_vacancies_template":null}},{"node":{"slug":"transparency","position":"6","title":"Transparency","description":null,"spaceId":"pj3y55rets5m","default_template":null,"cards_only_template":null,"tabs_for_files_template":[{"slug":"overview","title":"Overview","position":"1","parentMenu":{"slug":"transparency"}},{"slug":"france","title":"France","position":"2","parentMenu":{"slug":"transparency"}}],"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"careers","position":"7","title":"Careers","description":null,"spaceId":"pj3y55rets5m","default_template":[{"slug":"why-join-us","title":"Why Join Us?","position":"1","parentMenu":{"slug":"careers"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":[{"slug":"current-vacancies","title":"Current Vacancies","position":"2","parentMenu":{"slug":"careers"}}]}},{"node":{"slug":"partnering","position":"3","title":"Partnering","description":null,"spaceId":"pj3y55rets5m","default_template":[{"slug":"existing-partners","title":"Existing Partners","position":"2","parentMenu":{"slug":"partnering"}},{"slug":"partnering-objectives","title":"Partnering Objectives","position":"1","parentMenu":{"slug":"partnering"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"investors","position":"4","title":"Investors","description":null,"spaceId":"pj3y55rets5m","default_template":[{"slug":"corporate-governance","title":"Corporate Governance","position":"5","parentMenu":{"slug":"investors"}},{"slug":"aim-rule-26","title":"AIM Rule 26","position":"10","parentMenu":{"slug":"investors"}},{"slug":"analyst-coverage","title":"Analyst Coverage","position":"9","parentMenu":{"slug":"investors"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"media","position":"5","title":"PR Archive","description":null,"spaceId":"pj3y55rets5m","default_template":null,"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"research","position":"2","title":"Research","description":null,"spaceId":"pj3y55rets5m","default_template":[{"slug":"our-pipeline","title":"Our Pipeline","position":"2","parentMenu":{"slug":"research"}},{"slug":"clinical-trial-data-access-request","title":"Clinical Trial Data Access Request","position":"1","parentMenu":{"slug":"research"}}],"cards_only_template":null,"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}},{"node":{"slug":"about-us","position":"1","title":"About Us","description":{"content":[{"content":[{"value":"Founded in 2004, DIURNAL_SUPERSCRIPTTM_, a NEUROCRINE BIOSCIENCES Company_SUPERSCRIPTTM_, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency."}]}]},"spaceId":"pj3y55rets5m","default_template":[{"slug":"message-from-ceo","title":"Message From CEO","position":"2","parentMenu":{"slug":"about-us"}},{"slug":"company-profile","title":"Company Profile","position":"1","parentMenu":{"slug":"about-us"}}],"cards_only_template":[{"slug":"executive-team","title":"Executive Team","position":"5","parentMenu":{"slug":"about-us"}}],"tabs_for_files_template":null,"country_information_template":null,"current_vacancies_template":null}}]}}}